Researcher profile

David Grosshans

David Grosshans contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
4topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2020arXiv

A DNA damage multi-scale model for NTCP in proton and hadron therapy

{\bf Purpose}: To develop a first principle and multi-scale model for normal tissue complication probability (NTCP) as a function of dose and LET for proton and in general for particle therapy with a goal of incorporating nano-scale radio-chemical to macro-scale cell biological pathways, spanning from initial DNA damage to tissue late effects. {\bf Methods}: The method is combination of analytical and multi-scale computational steps including (1) derivation of functional dependencies of NTCP on DNA driven cell lethality in nanometer and mapping to dose and LET in millimeter, and (2) 3D-surface fitting to Monte Carlo data set generated based on post radiation image change and gathered for a cohort of 14 pediatric patients treated by scanning beam of protons for ependymoma. We categorize voxel-based dose and LET associated with development of necrosis in NTCP. {\bf Result}: Our model fits well the clinical data, generated for post radiation tissue toxicity and necrosis. The fitting procedure results in extraction of in-{\it vivo} radio-biological $α$-$β$ indices and their numerical values. {\bf Discussion and conclusion}: The NTCP model, explored in this work, allows to correlate the tissue toxicities to DNA initial damage, cell lethality and the properties and qualities of radiation, dose and LET.

preprint2020arXiv

A New Approach to Modeling the Microdosimetry of Proton Therapy Beams

{\bf Introduction}: To revisit the formulation of the mean chord length in microdosimetry and replace it by the particle mean free path appropriate for modelings in radio-biology. {\bf Methods}: We perform a collision-by-collision following by event-by-event Geant4 Monte Carlo simulation and calculate double-averaged stepping-length, $\langle\langle l \rangle\rangle$, for a range of target sizes from mm down to $μ$m and depth in water. We consider $\langle\langle l \rangle\rangle$ to represent the particle mean free path. {\bf Results}: We show that $\langle\langle l \rangle\rangle$ continuously drops as a function of depth and asymptotically saturates to a minimum value in low energies, where it exhibits a universal scaling behavior, independent of particle nominal beam energy. We correlate $\langle\langle l \rangle\rangle$ to linear density of DNA damage, complexities of initial lethal lesions and illustrate a relative difference between predictive RBEs in model calculations using mean chord length vs. the proposed mean free path. We demonstrate consistency between rapid increase in RBE within and beyond the Bragg peak and $\langle\langle l \rangle\rangle$, a decreasing function of depth. {\bf Discussion and conclusion}: An interplay between localities in imparted energy at nano-meter scale and subsequent physio-chemical processes, causalities and pathways in DNA damage requires substitution of geometrical chord length of cell nuclei by mean-free path of proton and charged particles to account for a mean distance among sequential collisions in DNA materials.